/

Tatiana Koudriavtseva1,2, Svetlana Lorenzano3, Maria Cellerino2,4

  • 1Medical Direction, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Regina Elena National Cancer Institute, Rome, Italy.

Frontiers in immunology
|August 16, 2023
PubMed
概括

组织因子是多发性硬化症 (MS) 发病的一个关键生物标志物,它将MS患者与对照患者区分开来,并将复发与缓解区分开来. 它还与大脑的血液动力学变化相关,表明其作为治疗点的潜力.

相关概念视频